Literature DB >> 7957542

Paracetamol pharmacokinetics during the first trimester of human pregnancy.

L Beaulac-Baillargeon1, S Rocheleau.   

Abstract

Paracetamol pharmacokinetics was evaluated in groups of pregnant (8-12 weeks) and non pregnant women given the standard oral dose of 650 mg. The mean half-life was significantly lower and oral clearance was significantly higher in the first trimester group compared to the control group. The AUC was lower in the first trimester but the difference was not significant. The maximum serum concentration (Cmax) was reached 48 min after administration in both groups, and the mean maximal serum concentration was similar in the pregnant and non-pregnant women (11.16 and 11.58 micrograms.ml-1). A correlation of r = 0.85 was found between Cmax and the weight of the pregnant women (P < 0.01) but not with the weight of the control women, this suggests that weight gain might be used to determine the women in whom dosage adjustment is needed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7957542     DOI: 10.1007/BF00191910

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  9 in total

Review 1.  Drug kinetics in pregnancy.

Authors:  B Krauer; F Krauer
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

2.  A survey of pharmacokinetic data from pregnant women.

Authors:  A J Cummings
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

3.  Increased metabolic clearance of acetaminophen with oral contraceptive use.

Authors:  D R Abernethy; M Divoll; H R Ochs; B Ameer; D J Greenblatt
Journal:  Obstet Gynecol       Date:  1982-09       Impact factor: 7.661

4.  Paracetamol metabolism in pregnancy.

Authors:  J O Miners; R A Robson; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

5.  Acetaminophen pharmacokinetics: comparison between pregnant and nonpregnant women.

Authors:  W Rayburn; U Shukla; P Stetson; E Piehl
Journal:  Am J Obstet Gynecol       Date:  1986-12       Impact factor: 8.661

6.  Influence of sex and oral contraceptive steroids on paracetamol metabolism.

Authors:  J O Miners; J Attwood; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

7.  Comparative pharmacokinetics of paracetamol in men and women considering follicular and luteal phases.

Authors:  J Wójcicki; B Gawrońska-Szklarz; J Kazimierczyk; Z Baskiewicz; A Raczyński
Journal:  Arzneimittelforschung       Date:  1979

8.  Absorption and metabolism of acetaminophen shortly before parturition.

Authors:  R E Galinsky; G Levy
Journal:  Drug Intell Clin Pharm       Date:  1984-12

Review 9.  Clinical pharmacokinetics of paracetamol.

Authors:  J A Forrest; J A Clements; L F Prescott
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

  9 in total
  6 in total

1.  Regulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination.

Authors:  H Jeong; S Choi; J W Song; H Chen; J H Fischer
Journal:  Xenobiotica       Date:  2008-01       Impact factor: 1.908

Review 2.  Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review.

Authors:  Gali Pariente; Tom Leibson; Alexandra Carls; Thomasin Adams-Webber; Shinya Ito; Gideon Koren
Journal:  PLoS Med       Date:  2016-11-01       Impact factor: 11.069

3.  Integration of Placental Transfer in a Fetal-Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus.

Authors:  Paola Mian; Karel Allegaert; Sigrid Conings; Pieter Annaert; Dick Tibboel; Marc Pfister; Kristel van Calsteren; John N van den Anker; André Dallmann
Journal:  Clin Pharmacokinet       Date:  2020-07       Impact factor: 6.447

Review 4.  Pharmacokinetics of HIV-Integrase Inhibitors During Pregnancy: Mechanisms, Clinical Implications and Knowledge Gaps.

Authors:  Ruben van der Galiën; Rob Ter Heine; Rick Greupink; Stein J Schalkwijk; Antonius E van Herwaarden; Angela Colbers; David M Burger
Journal:  Clin Pharmacokinet       Date:  2019-03       Impact factor: 6.447

5.  Physiologically Based Pharmacokinetic Modeling to Characterize Acetaminophen Pharmacokinetics and N-Acetyl-p-Benzoquinone Imine (NAPQI) Formation in Non-Pregnant and Pregnant Women.

Authors:  Paola Mian; John N van den Anker; Kristel van Calsteren; Pieter Annaert; Dick Tibboel; Marc Pfister; Karel Allegaert; André Dallmann
Journal:  Clin Pharmacokinet       Date:  2020-01       Impact factor: 6.447

Review 6.  Pharmacokinetic data in pregnancy: A review of available literature data and important considerations in collecting clinical data.

Authors:  Paola Coppola; Essam Kerwash; Janet Nooney; Amro Omran; Susan Cole
Journal:  Front Med (Lausanne)       Date:  2022-10-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.